💼 Business 2h ago · Jules Rimmer

View Channel →

0 0 Save Read Full Article Source ↗ 👁 0 💬 0

Revenue and profit forecasts fail to justify the hype baked into Moderna’s share price, according to Citi’s analysts.

Sign in to join the discussion

A tough job market is pushing more young Americans to make a big bet: on themselves

MarketWatch.com - Top Stories · 1h ago

The 15 worst-performing S&P 500 stocks during a dismal September

MarketWatch.com - Top Stories · 1h ago

‘We lived within our means’: I earned $30,000 as a pastor and still retired comfortably. Why don’t you tell people that?

MarketWatch.com - Top Stories · 2h ago

Adding Lilly’s new drug to Zepbound helped people lose up to 23% of their weight. But there were more side effects.

MarketWatch.com - Top Stories · 2h ago

This is the big risk that stock investors should be watching as rising bond yields menace markets

MarketWatch.com - Top Stories · 2h ago

Americans get back to their spending ways. Economy might be speeding up again.

MarketWatch.com - Top Stories · 3h ago